Trandolapril

群多普利

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrandolapril
Drug Alias NameTrandolaprilum泉多普利群哚普利UdrikPreran +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertensionMyocardial InfarctionCoronary Disease +[6] 
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1992/01/01
Country/TerritoryCanadaUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie IncTeva Pharmaceuticals Usa IncNational Heart, Lung, And Blood Institute (Nhlbi) +[4] 
Active IndicationsHypertension
Inactive IndicationsMyocardial InfarctionCoronary DiseaseMyocardial Ischemia +[5] 

Other Information

ATC CodeC09AA10
Related LinksWikipediaDrugBankKEGG